New Zealand markets closed
  • NZX 50

    -38.59 (-0.33%)

    -0.0020 (-0.32%)

    -23.40 (-0.32%)
  • OIL

    +0.13 (+0.15%)
  • GOLD

    +0.80 (+0.05%)

Outlook on the Proteomics Global Market to 2027 - Featuring Agilent Technologies, Bio-Rad Laboratories and Danaher Among Others

·10-min read
Company Logo
Company Logo

Dublin, July 07, 2022 (GLOBE NEWSWIRE) -- The "Proteomics Market - Global Outlook and Forecast 2022-2027" report has been added to's offering.

Proteomics is the extensive study of proteins. It is a rapidly growing field in disease diagnosis. Proteomics identifies disease-associated proteins and studies their function, structure, and expression. Proteomics researchers primarily rely on sophisticated technology to deliver actionable insights to advance the field because of the number of complexities in proteomics. Proteomics is a key tool in medical research because it makes it possible to study large-scale proteins from various biological samples to discover new protein biomarkers for different disease conditions.

Proteomics allows for discovering new protein biomarkers for diagnostic applications and the investigation of novel molecular targets for medication development and discovery. Protein expression profiling, targeted protein quantification, protein-protein interaction analysis, and post-translational modifications are all possible using proteomics. Proteomics has demonstrated its utility in biomarker identification, medication development, and precision medicine.

The following factors will drive the global proteomics market growth during the forecast period:

  • Increasing Number of Research and Development Activities in Proteomics

  • Rising Prevalence of Cancer and Various Genetic Disorders

  • Growing Focus on Development of Precision Medicine

Impact of COVID-19

The impact of COVID-19 is also seen in the proteomics market's growth. There has been increased research on diagnostics, biomarker discovery, and drug discovery and development against COVID-19. It has accelerated the involvement of proteomics. Several large and small companies have constantly been coming up with immunoassay kits to detect COVID-19 rapidly. Along with companies, many public/private research organizations and research institutes also increased the research on the coronavirus involving the proteomics approach extensively.

Proteomics plays a considerable role in drug development, and therefore, many drug manufacturers have started their proteomics divisions that fuel the growth of the global proteomics market.

Existing technologies have several drawbacks, including a lack of specificity, especially in high-multiplex assays, a lack of sensitivity, and a lack of precision; a limited dynamic range (the ability to measure a wide range of concentrations reliably and simultaneously); a high sample consumption requirement; a lack of scalability; a low throughput; data complexity; and a high cost. This scenario is changing over time and will enhance the scope of proteomics.

Proteomics technologies in the market include spectrometry, microarray, chromatography, and reagents used for proteomic analysis. The majority of proteomic analysis primarily relies on an expensive and complex analysis of proteome complexity at the level of amino acid variants, which have the potential to generate important biological insights.

Nanoproteomics offers real-time multiplexed analysis, rapid and miniatured assay, low sample consumption, and high sensitivity, thereby finding many applications for proteomic investigations.

The growing prominence of nanoproteomics offers significant growth opportunities for players in the market. Nanoproteomics is still in its early stage of enabling broad biomedical applications. In the upcoming years, continuous technological advancement in this field is anticipated. The growing prominence of nanoproteomics offers significant growth opportunities for players in this market.

BGI, a China-based company, has extensive experience in nanoproteomics. The company offers a nanoproteomics service, serving in more than 66 countries. Seer company's photograph product suite, an integrated solution, consists of the company's proprietary engineered nanoparticles, consumables, automation instrument, and software that allows proteomics studies. It reduces the complexity of traditional proteomics. It has commercialized its services using the proteograph product suite with North America, Europe, and the Asia Pacific providers.

Consumables & Reagent: Highest Revenue Contributor

The consumables and reagents segment has the largest market share accounting for 77.08% in 2021. For several decades, many companies have included both small and large companies, relentlessly working to bring more reagents and consumables used in all the areas of proteomics application in the initial step, which is during the sample preparation.

Many vital companies offer a wide range of consumables and reagents, such as Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific. An increase in the reagent's portfolio is evitable with the increasing proteomics research worldwide. These factors make the consumables and reagents segment the highest revenue maker, with $19.37 billion in 2021.

The instruments and software market is to grow at a CAGR of 13% from 2022 to 2027.

Most key companies offer a wide range of instruments for microarray, spectrometry, chromatography, electrophoresis, surface plasma resonance, and x-ray crystallography. With the increasing research on biomarker discovery and drug discovery and development, several pharmaceutical companies and academic & research institutes are expected to increase the implementation of instruments and software in their laboratories. Hence, the instruments & software segment is expected to increase in the forecast period with a CAGR of 13%.

End-user Insights

Among all the end-users, the pharmaceutical and biotechnology companies segment is growing due to the development and demand of the increasing diagnostic for drug development. The surge in the use of proteomic technology is also due to the rising adoption of precision medicine driven by biomarkers identification and discovery in response to the increasing prevalence of chronic diseases such as cancer mainly.

Several academic and research institutes are also the second major revenue generator in the proteomics market, increasing research on developing drugs and vaccines. Hospitals are also using proteomics technologies for disease diagnosis purposes. They either have their in-house pathology laboratory or collaborate with a diagnostic laboratory, and they get the diagnosis done by sending the samples. In collaboration or partnership with proteomics companies, several hospitals are enabling the companies to develop related proteomic technologies.

Forensic laboratories are also contributing and accounting for a good market share in growing the proteomics markets by receiving massive funding and investments to conduct research in forensic science for protein identification and biomarker discovery.

Vendor Analysis

Vendors are divided into both manufacturers and service providers. The proteomics market is highly dynamic and competitive, with global, regional, and local players offering a wide range of proteomics solutions. Agilent Technologies, Bio-Rad Laboratories, Thermo-Fisher Scientific, Danaher, and PerkinElmer are the significant players in providing products in proteomics, whereas BGI Group is a substantial player in offering proteomics services.

  • Expansion activities (regional business and facility expansions) are helping players strengthen the global distribution networks and thus allowing the players to explore untapped opportunities.

  • Increasing product launches

  • Large scale investments in the single-use bioprocessing probes and sensors market through varied conglomerates and investments firms

  • Forging collaborations and partnerships with well-established manufacturers, academic & research institutes, hospitals, and diagnostic & forensic laboratories is cementing the players' footprints.

  • Strategic acquisitions continue to be an essential competitive strategy for key players to expand their product offerings, access new technology, or increase market share.

  • In low and middle-income countries, the service providers are mainly in demand as these countries do lack proper healthcare infrastructure.

  • Service providers are focusing on increasing the collaborations with hospitals and several pharmaceutical companies to grow in the market.

The need for companies that provide proteomics services has drawn the attention of many researchers from laboratories that are not equipped with advanced technologies for proteomic research. This could be due to a lack of skilled professionals or in-house infrastructure, as increased demand for proteomics research. Many companies have emerged by providing protein identification, quantification, sequencing, purification, and custom assay services.

Key Questions Answered
1. How big is the global proteomics market?
2. What is the growth rate of the global proteomics market?
3. Who are the key players in the global proteomics market?
4. What are the growth factors in the global proteomics market?
5. What are the latest trends in the global proteomics market?

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of the Study

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview

8 Market Opportunities & Trends
8.1 Increasing Prominence of Nanoproteomics
8.2 Developments in Mass Spectrometry-Based Proteomics
8.3 Prominent Role of Proteomics in Diabetes Management

9 Market Growth Enablers
9.1 Rising Number of R&D Projects in Proteomics
9.2 Increasing Prevalence of Cancer and Various Genetic Disorders
9.3 Growing Focus on Development of Precision Medicine

10 Market Restraints
10.1 Limitations Associated With Accessing Proteome
10.2 Dearth of Skilled Professionals
10.3 Strict Regulatory Norms & High Cost of Instruments

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis

12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables & Reagents
12.4 Instruments & Software
12.5 Services

13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Drug Discovery & Development and Translational Research
13.4 Clinical Applications
13.5 Forensics & Applied Proteomics

14 End-user
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Pharmaceutical & Biotechnology Companies
14.4 Academic & Research Institutes
14.5 Hospitals
14.6 Diagnostic & Forensic Laboratories

15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview

16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 North America: Product Segmentation
16.4 North America: Application Segmentation
16.5 North America: End-User Segmentation
16.6 Key Countries

17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Europe: Product Segmentation
17.4 Europe: Application Segmentation
17.5 Europe: End-User Segmentation
17.6 Key Countries

18 Apac
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Apac: Product Segmentation
18.4 Apac: Application Segmentation
18.5 Apac: End-User Segmentation
18.6 Key Countries

19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Latin America: Product Segmentation
19.4 Latin America: Application Segmentation
19.5 Latin America: End-User Segmentation
19.6 Key Countries

20. Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Middle East & Africa: Product Segmentation
20.4 Middle East & Africa: Application Segmentation
20.5 Middle East & Africa: End-User Segmentation
20.6 Key Countries

21. Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis

22. Key Company Profiles
22.1 Agilent Technologies
22.2 Bio-Rad Laboratories
22.3 Danaher
22.4 Thermo Fisher Scientific
22.5 Perkinelmer
22.6 Bgi Group

23. Other Prominent Vendors - by Product
23.1 Bruker
23.2 Diasorin
23.3 Horiba
23.4 Illumina
23.5 Inoviq
23.6 Li-Cor Biosciences
23.7 Nautilus Biotechnology
23.8 Proteome Factory
23.9 Qiagen
23.10 Rhythm Biosciences
23.11 Shimadzu Scientific Instruments
23.12 Seer
23.13 Waters

24. Service Providers
24.1 Applied Biomics
24.2 Creative Proteomics
24.3 Poochon Scientific
24.4 Somalogic
24.5 Vproteomics

25. Product & Service Providers
25.1 Abcam
25.2 Anteotech
25.3 Ayoxxa Biosystems
25.4 Biognosys
25.5 Genei Laboratories
25.6 Grace Bio-Labs
25.7 Itsi-Biosciences
25.8 Msaid
25.9 Olink
25.10 Promega
25.11 Proteomics International
25.12 Quanterix

26. Report Summary

27. Quantitative Summary

28. Appendix

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting